The Positioning of Ceftobiprole in <i>Staphylococcus aureus</i> Bacteremia-Reference-Cited by-同舟云学术

The Positioning of Ceftobiprole in Staphylococcus aureus Bacteremia

Published:2024-03-11 Issue: Volume: Page:
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Membrillo de Novales Francisco Javier¹²^ORCID,Bravo de Pablo Olga²,Estella Ángel³^ORCID,Morata Ruiz Laura⁴^ORCID,Oltra Sempere Maria Rosa⁵,Salavert Lleti Miguel⁶^ORCID,Estébanez Muñoz Miriam¹^ORCID,Hidalgo-Tenorio Carmen⁷^ORCID

Affiliation:

1. CBRN and Infectious Diseases Department, Hospital Central de la Defensa “Gómez Ulla” , Spain

2. Internal Medicine Department, Hospital La Moraleja , Madrid , Spain

3. Intensive Care Department, University of Cádiz, Instituto de Investigación e Innovación Biomédica de Cádiz, Hospital Universitario de Jerez , Spain

4. Infectious Diseases Department, Hospital Clinic , Barcelona , Spain

5. Infectious Diseases Unit, Hospital Clinic Universitari Valencia , Spain

6. Infectious Diseases Department, Hospital La Fe , Valencia , Spain

7. Infectious Diseases Unit, Hospital Virgen de las Nieves , Granada , Spain

Funder

Fundación SEIMC-GESIDA

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciae123/57174645/ciae123.pdf

Reference8 articles.

1. Contemporary management of Staphylococcus aureus bacteremia—controversies in clinical practice;Minter;Clin Infect Dis,2023

2. A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia;Awad;Clin Infect Dis,2014

3. A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation;Nicholson;Int J Antimicrob Agents,2012

4. Ceftobiprole for treatment of complicated Staphylococcus aureus bacteremia;Holland;N Engl J Med,2023